New to shockwave or in pain for more than 3 months? Book a Telehealth to see if we can help you!
You’ve heard that shockwave therapy can help with chronic tendon pain, stubborn injuries, or conditions that haven’t responded to anything else. Maybe your physiotherapist mentioned it. Maybe you came across it after months of treatment that produced short bursts of improvement before the pain crept back.
But most explanations stop at “it uses acoustic waves to stimulate healing.” That’s technically true and practically useless.
What is actually happening at the cellular level when that applicator makes contact with your skin? What does your body do with those pressure waves? And why does something that sounds entirely mechanical produce a biological response that other treatments haven’t?
This is the explanation most people never get. And for anyone dealing with chronic pain, understanding the mechanism can change how you experience the treatment — and how well it works for you.
Results may vary. Always consult a healthcare provider before beginning any treatment.
To understand what focal shockwave therapy does, you first need to understand why chronic pain doesn’t simply resolve with time.
When tissue is injured — a tendon, a fascia, a bursa — the body launches an initial healing response. Blood flow increases. Inflammatory cells arrive. The tissue begins to repair. In acute injuries, this process works. You feel better in weeks.
But when tissue is repeatedly overloaded without adequate recovery, or when an injury crosses into the chronic phase, that healing response breaks down. The tissue enters what researchers describe as a degenerative state: disorganized collagen fibers, loss of normal cell activity, disrupted blood supply, and accumulated cell waste products.
This is not inflammation in the classic sense. Ice packs, anti-inflammatories, and rest do not address degenerated tissue — which is exactly why so many chronic pain patients try those approaches, feel marginally better for a while, and then find themselves back where they started.
The tissue has stopped repairing itself. It needs something to restart the process.
Focal shockwave therapy is one of the most well-researched tools for doing exactly that. Not by masking the pain signal, but by creating a targeted biological prompt inside the tissue itself.
The distinction between focal (also called focused) and radial shockwave matters here. Radial shockwave disperses energy in a cone pattern from the surface. Focal shockwave concentrates acoustic energy to a precise point deep within the tissue — often 3 to 5 centimetres below the skin — where chronic tendon or fascial pathology is actually located. This precision is why focal shockwave is preferred for deeper structures and more established degenerative changes.
Focal shockwave therapy generates short, high-energy acoustic pressure waves — not sound waves you can hear, but mechanical pressure pulses that travel through tissue at high speed. When these waves reach the target zone, two things happen simultaneously.
First, the waves create micro-mechanical stress on the cells in the treatment area. This stress is enough to stimulate cellular activity but well below the threshold of causing damage to healthy surrounding tissue.
Second, the waves trigger cavitation — the formation and rapid collapse of microscopic gas bubbles in the tissue fluid. When these bubbles implode, they release a focused burst of energy that creates a micro-trauma response at the treatment site.
This micro-trauma is the key. The body responds to it the same way it responds to any injury: it launches a repair cascade. But this time, it does so in tissue that had stopped repairing on its own.
One of the most significant findings from shockwave research is the stimulation of neovascularization — the formation of new blood vessels in the treated area. Degenerative tissue typically has poor blood supply, which is one reason it fails to heal. Focal shockwave creates the conditions for the tissue to rebuild its own vascular network.
Alongside this, shockwave exposure has been shown to upregulate growth factors — biological signals that tell cells to proliferate and produce new structural proteins. Studies have found increased levels of transforming growth factor-beta (TGF-β) and insulin-like growth factor (IGF-1) following shockwave treatment, both of which play central roles in tissue repair and collagen production.
Tendons and fascia are made primarily of collagen — specifically, organized collagen fibers aligned to handle mechanical load. In degenerated tissue, this organization breaks down. The fibers become disorganized and lose their ability to transmit force efficiently.
Focal shockwave has been shown to stimulate tenocytes — the cells responsible for producing and maintaining tendon collagen — to increase collagen synthesis and reorganize existing fibers. Over a series of treatments, this produces measurable structural improvements in the tissue that show up on imaging and correlate with clinical pain reduction.
There is also a neurological dimension to shockwave therapy that is often overlooked. Chronic pain is partly a tissue problem and partly a nervous system problem. When tissue is in pain for a long time, the local nerve fibers become hypersensitized — they fire pain signals more easily and at lower thresholds.
Focal shockwave has been shown to temporarily deplete substance P, a neuropeptide that amplifies pain signaling in damaged tissue. This creates a window of reduced pain sensitivity that can make early rehabilitation easier — and may be part of why patients often notice a significant drop in pain after the first two to three sessions.
Understanding the biology is one thing. Knowing what the treatment actually feels like is another.
Most patients describe the experience as unfamiliar rather than painful — an intense pressure or rapid tapping at the site being treated. The sensation varies depending on the area, the depth of the target tissue, and individual pain sensitivity.
At the start of a session, an ultrasound gel is applied to the skin over the treatment area. This gel acts as a coupling medium — it allows the acoustic waves to transfer from the applicator into the tissue without losing energy at the skin surface. The applicator is then pressed firmly against the skin.
When the device activates, most people feel something like a deep tapping or knocking against the tissue. Some describe it as a rubber mallet sensation — firm, rhythmic, concentrated. If the tissue being treated is acutely tender, the first few pulses can feel intense. Within a minute or two, as the treatment area desensitizes, the sensation usually becomes more tolerable.
A typical session runs between 10 and 20 minutes. Most treatment protocols involve three to six sessions, spaced five to seven days apart to allow the biological response to progress between visits.
After the session, it is normal to experience some soreness at the treatment site for 24 to 48 hours. This is not a sign that something went wrong. It is the tissue responding to the stimulus — the initial phase of the repair cascade that the treatment was designed to trigger.
What most patients notice over the course of a full treatment series is a gradual pattern: initial soreness after the first session, a reduction in baseline pain by sessions two to three, and steadily improving function through sessions four to six. Individual responses vary, and some patients with more established degeneration take longer to respond.
“Shockwave therapy at the Unpain Clinic genuinely changed my life. In my early twenties I was told lower back surgery was my only hope after a disc injury. Over 10 years later I have never had that surgery, and Uran is a huge reason why. Over the years I have seen Uran for everything from chronic lower back management to a pinched nerve from the gym and even a head and neck injury from a skidsteer accident. Every single time he has had the tools, the experience, and the plan to get me recovering the right way. If you are dealing with chronic pain or an injury and want to actually fix it, I cannot recommend Uran and the Unpain Clinic enough.”
— Dillan Ross
Focal shockwave is not a passive treatment. It works best when the biological stimulus it creates is supported by what happens outside the clinic. These are not replacements for professional care — they are supporting strategies for the tissue in between sessions.
After each shockwave session, the tissue is in an active repair state. Gentle, controlled loading through that tissue — the right exercises at the right volume — helps direct the new collagen fibers to organize along the lines of mechanical stress. This is why loading exercises are prescribed alongside shockwave rather than instead of it.
Your clinician will give you specific exercises appropriate to your case. The general principle: don’t rest completely, but don’t push into sharp pain either. Mild discomfort with controlled movement is typically appropriate.
Shockwave gives the tissue a biological signal to repair, but if external load spikes continue during the recovery window, that signal gets overwhelmed. A long walk the day after a session, a return to full training too quickly, or sustained standing on hard surfaces can slow the process down.
The practical rule: keep activity consistent and avoid sudden increases of more than 10% in total load from week to week during your treatment series.
Tissue repair happens primarily during sleep — when growth hormone is released and inflammatory byproducts are cleared. If you are sleeping poorly during a treatment series, the biological response to shockwave will be blunted. Seven to nine hours of quality sleep is not a luxury during a treatment protocol. It is part of the treatment.
No. This is one of the most common points of confusion. Therapeutic ultrasound uses continuous or pulsed sound waves at low intensity to gently warm tissue and promote mild circulation. Focal shockwave uses high-energy acoustic pressure pulses — the energy levels are orders of magnitude higher, and the mechanism of action is fundamentally different. Shockwave creates a micro-trauma and regenerative response; ultrasound does not. They are entirely separate modalities.
The sensation is intense but manageable for most patients. The experience varies depending on the area being treated and how sensitive the tissue is. Most patients describe it as a firm, deep tapping uncomfortable at first, less so as the treatment progresses. After the session, 24 to 48 hours of soreness is normal and expected.
Shockwave has the strongest evidence base in musculoskeletal conditions involving chronic tendon and fascial degeneration: plantar fasciitis, Achilles tendinopathy, patellar tendinopathy, rotator cuff tendinopathy, lateral epicondylitis (tennis elbow), and greater trochanteric pain syndrome, among others. Research also supports its use in calcific tendinitis, stress fractures, and certain soft tissue conditions.
Radial shockwave disperses energy from the applicator tip outward in a cone pattern, affecting a broader, shallower area. Focal shockwave concentrates energy to a specific focal point deep within the tissue — often 3 to 5 centimetres below the skin surface. Focused shockwave is generally preferred for deeper structures and more established pathology. Your clinician will recommend the appropriate type based on your assessment findings.
Coverage varies significantly by insurer and plan. In Canada, extended health benefit plans through employers sometimes cover shockwave therapy when billed under physiotherapy. It is worth contacting your insurance provider directly to ask whether ESWT (extracorporeal shockwave therapy) is a covered modality under your physiotherapy or rehabilitation benefit. Many clinics can provide a detailed receipt for direct submission or reimbursement.
Not all physiotherapy clinics that offer shockwave use focused shockwave equipment. When searching for a provider, ask specifically whether they use a focused or focal shockwave device — as opposed to radial — and whether the clinician has specific training in shockwave application. A formal assessment should precede treatment to confirm that shockwave is appropriate for your specific condition and tissue state.
Most treatment protocols involve three to six sessions, delivered five to seven days apart. Some patients respond quickly — meaningful pain reduction within two to three sessions. Others, particularly those with long-standing degeneration, may require a full course before noticing sustained improvement. Your clinician should set clear expectations after your initial assessment based on the severity of your tissue findings.
Focal shockwave therapy is not a shortcut or a passive fix. It is a targeted biological tool one that creates the conditions for tissue repair in structures that have stopped healing on their own.
The mechanism is specific: acoustic pressure waves trigger cavitation, micro-trauma, neovascularization, growth factor release, and collagen reorganization in degenerated tissue. The result, when combined with appropriate loading and recovery, is measurable structural improvement that correlates with lasting pain reduction — not temporary symptom suppression.
If you have been managing chronic pain with rest, ice, or injections without lasting results, understanding this distinction matters. The tissue needs stimulation, not silence. And focal shockwave therapy is one of the most direct ways to deliver that stimulus at depth.
Stop guessing, stop collecting random treatments, and get a plan that treats the system, not just the symptom.
60-minute one-on-one session. Here’s what’s included:
Full-body movement and strength assessment
Identify which pain drivers matter for your case
Review of history and imaging if available
Clear written plan with transparent pricing before you commit
No referral needed. No obligation to continue beyond the first visit.
No pressure, no contracts.
We will tell you honestly at the assessment if we don’t believe you’re a good candidate for this approach. If your condition needs something different, we’ll refer you directly.
Author: Uran Berisha, BSc PT, RMT, Shockwave Expert
Unpain Clinic | unpainclinic.com
1. Wang CJ. Extracorporeal shockwave therapy in musculoskeletal disorders. J Orthop Surg Res. 2012;7:11. https://pubmed.ncbi.nlm.nih.gov/22433113/
2. Ogden JA, Tóth-Kischkat A, Schultheiss R. Principles of shock wave therapy. Clin Orthop Relat Res. 2001;(387):8-17. https://pubmed.ncbi.nlm.nih.gov/11400873/
3. Notarnicola A, Moretti B. The biological effects of extracorporeal shock wave therapy (ESWT) on tendon tissue. Muscles Ligaments Tendons J. 2012;2(1):33-37. https://pubmed.ncbi.nlm.nih.gov/23738275/
4. Vetrano M, d’Alessandro F, Torrisi MR, Ferretti A, Vulpiani MC, Visco V. Extracorporeal shock wave therapy promotes cell proliferation and collagen synthesis of primary cultured human tenocytes. Knee Surg Sports Traumatol Arthrosc. 2011;19(12):2159-2168. https://pubmed.ncbi.nlm.nih.gov/21290100/
